To tackle HIV-@ variation , we designed a unique T-cell immunogen HIVconsv from functionally conserved regions of the HIV-@ proteome , which were presented to the immune system using a heterologous prime-boost combination of plasmid DNA , a non-replicating simian ( chimpanzee ) adenovirus ChAdV-@ and a non-replicating poxvirus , modified vaccinia virus Ankara .